Viztek and Matakina have announced a new partnership to integrate Matakina’s VolparaDensity software for analyzing digital mammography and tomosynthesis images and objectively assessing breast density with the Viztek Opal-PACS and Opal-wRIS for streamlined reporting and workflow. With 13 states having enacted legislation requiring patient notification and reporting of breast density, hospitals and imaging centers can now benefit from a streamlined workflow and integrated reporting to meet these mandates and streamline patient care.
“Our integration with VolparaDensity extends our capabilities and enables us to provide a more complete women’s healthcare software suite,” said Steve Deaton, vice president at Viztek. “With viewing, tracking, and now breast density software integration for RIS and PACS, Viztek has the first complete package for mammography and is enabling increased efficiency with the potential for better results.”
Cleared by the FDA, HealthCanada, the TGA and CE-marked in Europe, VolparaDensity is in use at sites across the globe helping radiologists assess breast density more objectively and enabling them to better consider who might benefit from additional screening. Highly correlated to breast MR assessments, VolparaDensity generates an objective, automatic measurement of volumetric breast density and an FDA-cleared BI-RADS breast density category.
